The majority of adverse events seen in clinical trials are those expected from already administered chemotherapy
Most common side-effects potentially related to Savene® therapy are nausea/vomiting, diarrhea, stomatitis, injection site pain, haematological toxicities and increased hepatic transaminases
All adverse reactions have been rapidly reversible and easily manageable
All available clinical evidence suggests that Savene® has a favourable tolerability profile[14]